Create a free Global Cosmetic Industry account to continue reading

Ashland Targets Skin Longevity with Triple Play in Mitochondria, Exosomes and Soothing Science

Eternight lands squarely in the longevity megatrend, translating complex mitobiology into digestible claims like slow aging, biological age reversal and night-repair amplification.
Eternight lands squarely in the longevity megatrend, translating complex mitobiology into digestible claims like slow aging, biological age reversal and night-repair amplification.
puhhha at Adobe Stock

Ashland is launching  a trio of ingredients that push longevity science, exosome signaling and biomimetic soothing into sharper commercial focus, giving formulators new performance levers and marketers fresh, future-facing claims territory.

Eternight biofunctional is an AI-enhanced Iris pallida root extract built around mitopeptide signaling and mitochondrial optimization. Positioned as a skin-eternity messenger, the active targets the 12 hallmarks of aging through what Ashland calls [3R] longevity science: rest, restore and reverse.

For formulators, the hook is multi-pathway efficacy: mitochondrial support, nocturnal repair mimicry and measurable age-reversal claims (up to four years younger appearance in one month via AI analysis). That creates a rare convergence of biotech storytelling and quantifiable results—ideal for high-performance serums, night treatments and premium anti-aging franchises.

For marketers, Eternight lands squarely in the longevity megatrend, translating complex mitobiology into digestible claims like slow aging, biological age reversal and night-repair amplification. It’s a narrative bridge between wellness, skin healthspan and visible results.

With its Exoblossom platform, Ashland is advancing plant-derived exosome-like nanovesicles (PELNs). Using its PSR (plant small RNA) technology, the company is isolating bioactive vesicles from flowers like rose, lavender and jasmine to enhance intercellular communication, a key aging pathway.

For formulators, this opens a new frontier in delivery and signaling: actives that help cells “talk” to each other more effectively. The result is a platform for regeneration, repair and next-gen skin intelligence formulations.

For marketers, exosomes are quickly becoming a premium skin care shorthand. Ashland’s botanical, sustainably sourced angle—paired with epigenetic science—offers differentiation from human- or biotech-derived exosome claims, with cleaner positioning and strong regulatory alignment (e.g., COSMOS-approved inputs).

Rounding out the launches is Vital et sp biofunctional, a water-soluble, bioavailable vitamin E derivative complex designed to activate the skin’s calming power. It targets multiple stressors—UV, mechanical, bacterial and senescence-related—while outperforming tocopherol acetate.

For formulators, it’s a highly versatile, easy-to-use solution: water compatibility, proven delivery and broad application from after-sun to acne care to anti-aging. The phenoxyethanol-free preservation system also aligns with current formulation pressures.

For marketers, Vital et sp taps into the silent skin narrative—less redness, less irritation and more resilience—supporting claims around sensitive skin, post-treatment care and active lifestyles.

More in Skin Care